Gerlof D. Valk

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink et al. · Nature Medicine · 2019 · 179 citations · Full text

Tumor Biology, Pancreatic Cancer, Medicine +6

Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study

Frédéric Castinetti, Xiao-Ping Qi, Martin K. Walz et al. · The Lancet Oncology · 2014 · 178 citations · Full text

Total Adrenalectomy, Endocrine Oncology, Urology +7

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors

Roeland F. de Wilde, Christopher M. Heaphy, Anirban Maitra et al. · Modern Pathology · 2012 · 174 citations

Pancreatic Cancer, Medicine, Alternative Lengthening +8

Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)

Joanne M. de Laat, Olaf M. Dekkers, Carolina R C Pieterman et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 150 citations · Full text

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

Karin Frank‐Raue, Lisa Rybicki, Zoran Erlic et al. · Human Mutation · 2010 · 149 citations · Full text